Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

“A Highly Kinetic Period” – Goldman’s Hedge Fund Honcho Reflects On H1… & What Lies Ahead

% of readers think this story is Fact. Add your two cents.


“A Highly Kinetic Period” – Goldman’s Hedge Fund Honcho Reflects On H1… & What Lies Ahead

The first half of 2025 was a highly kinetic period, to say the least, according to Goldman Sachs head of hedge fund coverage, Tony Pasquariello.

With a touch of distance from the screens this week, he went back and read a bunch of his recent notes, which served as a reminder of the immense narrative volatility along the path.

For example:

  • US exceptionalism was a bright and shining consensus position at the start of the year…

  • …that gave way to the worst short-cycle selloff in domestic equities since the depths of COVID…

  • …only to see S&P close out H1’25 on the dead highs (and we’ve kept going).

What follows from here is a set of views that Pasquariello took away from the past six months — with an eye towards the next six months…

MARKET DIRECTION:

- given all of the uncertainty and volatility, it’s hard to look back and NOT be a little impressed with how the US economy has performed.

- remember, in the toughest moments of April, many folks believed that a US recession was all but in the bag. 

- in practice, the risk management challenge was two-fold: calibrating huge changes to US political orthodoxy — at the exact time as new and disruptive technologies were colliding. 

- if you flash forward to today — with NDX nearly 40% off the lows — Mr. Market has added another data point to this analog: periods of exceptionally high policy uncertainty usually give way to strong equity returns.

- the April shakeout also calls to mind this well-worn rule of thumb: within a structural bull market, if you want to be short US equities, your timing needs to be impeccable. 

- now, in trying to work out how the market recovered the highs, perhaps it’s simply because governments, corporates and households stayed on the gas.

- don’t take my word for it, simply look at the trajectory of US fiscal spending … or the capex plans of the Magnificent Seven … or US retail demand for stocks.

- looking forward, the bull case is this: the US economy is durable, financial conditions are easy and we’re witnessing a remarkable acceleration of applied innovation. 

- set against that, growth is apt to slow during the second half, risk/reward at this multiple isn’t alluring and global bond markets skate on thin ice (witness the UK again this week).

- in the end, it’s still a bull market, yet one that’s delivering less convexity and less consistency than before — I wrote that earlier in the year, and I’m sticking with it.

- core positions that I believe in (and would marry as a composite): US technology / US power … steeper global yield curves … a (somewhat) weaker dollar … and don’t fight the primary trend in gold. 

A SHORT SET OF THOUGHTS ON US TECH:

- I’ve long believed that this space offers elements of sword AND shield — while there were some moments when both the sword and the shield had gone missing, NDX finished H1’25 up a very respectable 8%.

- if Q1 was marked by the swing from Stargate euphoria to DeepSeek disruption, Q2 was marked by remarkable earnings news and an unrelenting commitment to capex. 

- taken together, both champions and challengers were on the offensive, such that demand for compute was some form of insatiable … I don’t see that changing anytime soon.

- in addition, while the sensation around AI is shifting in the press (namely the risk of impingement on jobs), the capex stories were a clear support for the market (which could only amplify the societal challenges).

- valuation: as Pete Callahan notes, NDX currently trades on a 28x P/E, roughly in line with its 5-year average; while not a tailwind, I don’t regard that as a headwind, either.

- what has clearly changed: in both 2023 and 2024, every stock in the Magnificent Seven rallied; at the halfway point this year, you had three up / three down / one flat.

Conclusion: stay in the pocket, particularly into the seasonal sweet spot that is July.

US VS ROW:

- lest it be said, after a very long (and very powerful) run, the US was NOT the best game in town. 

- with a hefty slice of humble pie, I have to give credit to European equites — it was hard to make up a bullish story at the end of last year, but the fact set changed, and specific pockets totally shined (witness the DAX, the banks, the defense names). 

- so, whether it was the game change in European defense spending — or the lightning strike that was DeepSeek — there were a few fundamental inflections that played to the strengths of non-dollar markets.

- now the question is whether structural allocators of capital will sell their holdings of US equities and put the chips elsewhere — again, I doubt it, and think the dollar bears the brunt of things for now.    

- in the context of that question, Brett Nelson highlighted a recent WSJ article that reminds us of a clear truth: over the past 50 years, Europe has created (from scratch) 14 companies with a market capitalization of more than $10bn; the US has created 241.

- I also found this week’s headline that AstraZeneca is considering a move of their listing from the UK to the US to be notable (when the headline hit, it was the single largest weight in the FTSE).

- in effect, this was the real story of the first half: it was a bull market for GLOBAL equity indices — simply pull up a chart of MXWO — where the US didn’t do all of the heavy lifting. 

THE OTHER BIG DYNAMICS IN THE GAME:

- The Fed: our call is now for sequential cuts in September / October / December … then two more moves in March and June of next year … taking the terminal rate down to 3-1/8%.

- on geopolitics, I’d argue that recent months underscore two long standing observations: (1) no one really knows anything; (2) markets have no moral conscience and tend to move on from things.

- the dollar: this was the joker in the pack, from consensus long to start the year to consensus short by the end of Q2; given the Fed is set to out-ease everyone, and given more pressure on USD hedge ratios, again I suspect the path of least resistance is to the downside.

- if there’s a bolt-on to the prior line, it’s that I find it really hard to pick other currencies that I actually want to own — which, of course, leads one back to gold

- the deficit / debt sustainability: the first half was proof of how this variable comes in and out of market focus on a random cadence, leaving both bulls and bears with more questions than answers; I suspect it will be with us for a long while, and argues for steeper curves / more term premium.

- flows, positioning: it never ceases to amaze me how market technicals can hold so much sway at market inflection points; I can only assume that technical discipline will continue to matter in the second half (the current bias is favorable, thanks to retail and systematic strategies).

- a follow-on from the prior line: I’d keep a close eye on gross exposures — which have been running very high, and saw a significant pressure test this week (e.g. the violent breakdown in the momentum factor).

- breadth: yes, this has been a narrow rally, but such is life in a top heavy index; said another way, I don’t buy the old wisdom that poor breadth means S&P is an unhealthy asset.  

- valuation: S&P trades on an objectively elevated multiple, yet that fact alone hasn’t stood in the way of progress, and I suspect the onus is now on earnings to carry the load. 

- bitcoin: brick-by-brick, I think it continues to achieve a modicum of respect as a long-term store-of-value (as much of the altcoin universe struggles).

- stablecoins: this theme came on like a wildfire, and I suspect it isn’t going to magically disappear anytime soon;.

- hedge funds: you know my bias, but the fact is both discretionary and systematic managers are performing well.

- the celebration of July 4th, I agree with this wisdom from the great Warren Buffett: “we’re always in the process of change, and we’ll always find all kinds of things to criticize in the country … but the luckiest day in my life is the day I was born, because I was born in the United States.”

Finally, a chart for the road…

…one that invites as big a question as any right now. 

With thanks to Brett Nelson, this plots earnings growth of the US vs various cuts of ROW (12-month trailing EPS, expressed in local FX).

To my eye, it clearly demonstrates why US equities have outperformed so much in the post-GFC era (particularly post-COVID). 

Now the debate turns on whether that immense gap is set to converge, or not:

More here from Goldman Sachs Sales & Trading team available to pro subs.

Tyler Durden Fri, 07/04/2025 – 16:00


Source: https://freedombunker.com/2025/07/04/a-highly-kinetic-period-goldmans-hedge-fund-honcho-reflects-on-h1-what-lies-ahead/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.